NCT06743802

The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery

The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery: a Randomized Controlled Trial

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 264 (estimated)
• Sponsor: The Second Affiliated Hospital of Chongqing Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study aimed to assess the effectiveness of Coenzyme Q10 in preventing both acute and chronic pain following thoracoscopic surgery, with a focus on its potential benefits in reducing the incidence and severity of pain.

Conditions

• Postoperative Pain

Interventions

Type	Name	Description
DRUG	Coenzyme Q10	Coenzyme Q10 was administered from admission to one month after discharge at a dose of 200 mg per day (200 mg/qd).
OTHER	Placebo	The placebo was administered from hospital admission until one month after discharge.

Timeline

• Start date: 2025-01-09
• Primary completion: 2026-03-20
• Completion: 2026-03-20
• First posted: 2024-12-20
• Last updated: 2025-02-26

Locations

1 site across 1 country: China